ULTRAGENYX PHARMACEUTICAL IN (RARE) — institutional ownership
326 funds reported holding ULTRAGENYX PHARMACEUTICAL IN in their latest 13F filings, worth $3.94B in total (CUSIP 90400D108).
Largest holders
- BlackRock, Inc. (BLK) — $356M
- RTW INVESTMENTS, LP — $260M
- VANGUARD GROUP INC — $236M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $227M
- AQR CAPITAL MANAGEMENT LLC — $214M
- STATE STREET CORP (STT, STT-PG) — $206M
- VANGUARD CAPITAL MANAGEMENT LLC — $143M
- TWO SIGMA INVESTMENTS, LP — $121M
- SANDS CAPITAL MANAGEMENT, LLC — $105M
- JACOBS LEVY EQUITY MANAGEMENT, INC — $98.2M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Izzy Englander portfolio (Millennium Management)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Ken Griffin portfolio (Citadel Advisors)